Vaccine Information Statement (VIS) -- Tdap (Tetanus, Diphtheria, Pertussis) Vaccine: What You Need to Know
This two-page Vaccine Information Statement (VIS) educates people about the Tdap vaccine, which protects from tetanus (Lockjaw), diphtheria, and pertussis (whooping cough), and can be given to pregnant women to protect newborn babies against pertussis. It describes symptoms, transmission, and effects of each disease. It explains why people should get the Tdap vaccine, and who should be vaccinated and when, clarifying that pregnant women should get a dose during every pregnancy. The VIS identifies who should not get the vaccine or should wait. It identifies risks and side effects, distinguishes between mild, moderate, and severe problems, and explains what to look for and what to do in the event of a serious allergic reaction. Contact information for the National Vaccine Injury Compensation Program (VICP) is provided, along with tips for how people can learn more about the Tdap vaccine.
The English-language VIS was created by the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases. The translations are provided by the Immunization Action Coalition (IAC) and its partner organizations.
A qualified translation company performed an independent review by a second translator, and a client advocate.